BioNTech and OncoC4 will co-develop OncoC4’s ONC-392 as a monotherapy or combina...
Predictive Oncology’s PEDAL platform enables more informed selection of drug-tum...
The strategic efforts from two companies have raised the profile of NASH, an ind...
The partnership will focus on developing mRNA vaccines to treat certain autoimmu...
Pharmaceutical Technology analyses recent regulatory and trial announcements tha...
The collaboration will develop intranasal preventatives for influenza, respirato...
The therapeutic properties of Cannabidiol (CBD) - a pure natural ingredient extr...
GS-6791 is the first development candidate from the previous collaboration betwe...
One panelist was paid nearly $27,000 in recent years by Novo Nordisk, which sell...
The Arizona Department of Corrections is promising a federal judge that it will ...
An FDA official says accelerated approval should be extended to gene therapies f...
A Pentagon study has found high rates of cancer among military pilots and for th...
STAT sits down with Included Health to discuss how the relationship between pati...
Makers of flu vaccines say they could manufacture hundreds of millions of bird f...
“The field is open for Nuance to really accelerate their product development and...
Karuna Therapeutics said its treatment for schizophrenia reduced psychosis repor...
